Breaking News Instant updates and real-time market news.

PRTO

Proteon Therapeutics

$1.71

(0.00%)

17:21
11/06/18
11/06
17:21
11/06/18
17:21

New Leaf Biopharma reports 8.6% passive stake in Proteon Therapeutics

PRTO Proteon Therapeutics
$1.71

(0.00%)

05/10/18
HCWC
05/10/18
UPGRADE
Target $3
HCWC
Buy
Proteon Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth upgraded Proteon Therapeutics to Buy and raised his price target for the shares to $3 from $2.30. With the pivotal Phase 3 Patency-2 study on track to report top line results in Q1 of 2019, the company warrants consideration, Ramakanth tells investors in a research note. The study is a 603-patient, double-blind, placebo-controlled evaluating the use of Proteon's lead product, vonapanitase, to extend fistula patency for hemodialysis in patients with chronic kidney disease, the analyst points out. He believes the protocol amendments "significantly" improve the study's probability of success.
10/30/18
MAXM
10/30/18
INITIATION
MAXM
Buy
Proteon Therapeutics initiated with a Buy at Maxim
Maxim analyst Jason McCarthy started Proteon Therapeutics with a Buy rating and $5 price target, stating that he likes the risk/reward scenario for a positive outcome of the company's second Phase 3 trial in hemodialysis fistula creation, which has data expected in March 2019.
10/30/18
MAXM
10/30/18
INITIATION
Target $5
MAXM
Buy
Proteon Therapeutics initiated with a Buy at Maxim
Maxim analyst Jason McCarthy initiated Proteon Therapeutics with a Buy rating and a price target of $5. The analyst notes the evaluation of the company's Vonapanitase in its second expanded phase 3 trial in hemodialysis fistula creation with data expected in March of 2019. McCarthy states that the protocol amendments of this PATENCY-2 study support his view of a positive outcome, adding that the stock trades at an attractive valuation on risk-reward basis.
10/30/18
10/30/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Livent (LTHM) initiated with a Market Perform at BMO Capital. 2. Elastic (ESTC) initiated with a Buy at BofA/Merrill and Goldman Sachs, an Outperform at RBC Capital, an Overweight at Barclays, a Hold at Canaccord and Jefferies, as well as a Neutral at Citi and JPMorgan. 3. Lithium Americas (LAC) initiated with a Market Perform at BMO Capital. 4. Ventas (VTR) initiated with a Neutral at JPMorgan. 5. Proteon Therapeutics (PRTO) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CRUS

Cirrus Logic

$40.00

0.85 (2.17%)

08:48
02/19/19
02/19
08:48
02/19/19
08:48
Conference/Events
Cirrus Logic management to meet with Cowen »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

ECL

Ecolab

$163.45

1.82 (1.13%)

08:47
02/19/19
02/19
08:47
02/19/19
08:47
Earnings
Ecolab reports Q4 adj. EPS $1.54, consensus $1.54 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 28

    May

ORTX

Orchard Therapeutics

$15.08

0.58 (4.00%)

08:47
02/19/19
02/19
08:47
02/19/19
08:47
Conference/Events
Orchard Therapeutics management to meet with Cowen »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

GSK

GlaxoSmithKline

$41.24

0.38 (0.93%)

08:46
02/19/19
02/19
08:46
02/19/19
08:46
Conference/Events
GlaxoSmithKline management to meet with Cowen »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 18

    May

GMDA

Gamida Cell

$13.25

0.3 (2.32%)

, EDIT

Editas Medicine

$20.09

0.22 (1.11%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Hot Stocks
Gamida Cell, Editas Medicine announce agreement to evaluate use of CRISPR tech »

Gamida Cell (GMDA)…

GMDA

Gamida Cell

$13.25

0.3 (2.32%)

EDIT

Editas Medicine

$20.09

0.22 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EXPD

Expeditors

$73.56

-0.45 (-0.61%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Earnings
Expeditors reports Q4 EPS $1.02, consensus 85c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPO

Midstates Petroleum

$9.25

-0.17 (-1.80%)

, AXDX

Accelerate Diagnostics

$19.82

0.65 (3.39%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

MPO

Midstates Petroleum

$9.25

-0.17 (-1.80%)

AXDX

Accelerate Diagnostics

$19.82

0.65 (3.39%)

WATT

Energous

$8.91

0.11 (1.25%)

CRON

Cronos Group

$21.28

0.46 (2.21%)

NIO

NIO Inc.

$7.41

-0.07 (-0.94%)

EPD

Enterprise Products

$28.21

0.01 (0.04%)

NBEV

New Age Beverages

$6.50

-0.08 (-1.22%)

ITB

iShares U.S. Home Construction ETF

$35.22

0.36 (1.03%)

CWH

Camping World

$15.11

-0.105 (-0.69%)

SAND

Sandstorm Gold

$5.49

0.06 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 04

    Mar

WBC

Wabco

$116.78

0.19 (0.16%)

08:44
02/19/19
02/19
08:44
02/19/19
08:44
Recommendations
Wabco analyst commentary  »

Baird would be aggressive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$3.80

0.28 (7.95%)

08:43
02/19/19
02/19
08:43
02/19/19
08:43
Conference/Events
Adverum Biotechnologies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

DPZ

Domino's Pizza

$281.63

-5.46 (-1.90%)

08:43
02/19/19
02/19
08:43
02/19/19
08:43
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Conference/Events
UBS pharmaceuticals analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

GVA

Granite Construction

$45.48

0.59 (1.31%)

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Hot Stocks
Granite's Water and Mineral Services Group awarded $22.5M in sewer projects »

Granite announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

WWW

Wolverine World Wide

$39.54

0.94 (2.44%)

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Recommendations
Wolverine World Wide analyst commentary  »

Fresh Pick designation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MCEP

Mid-Con Energy

$0.98

0.06 (6.52%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Hot Stocks
Mid-Con Energy sell Texas properties for $60M, buys Oklahoma assets for $27.5M »

Mid-Con Energy, through…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$16.95

(0.00%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Recommendations
Kratos Defense analyst commentary  »

Kratos Defense price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

PEP

PepsiCo

$115.89

3.4 (3.02%)

, KO

Coca-Cola

$45.25

-0.345 (-0.76%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Upgrade
PepsiCo, Coca-Cola rating change  »

Macquarie upgrades…

PEP

PepsiCo

$115.89

3.4 (3.02%)

KO

Coca-Cola

$45.25

-0.345 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 18

    May

HMST

HomeStreet

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Recommendations
HomeStreet analyst commentary  »

HomeStreet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSIC

Henry Schein

$62.38

0.03 (0.05%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Recommendations
Henry Schein analyst commentary  »

Henry Schein price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

AEO

American Eagle

$20.07

-0.03 (-0.15%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Hot Stocks
American Eagle announces license agreement to expand brands to Europe »

American Eagle Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Hot Stocks
Genuine Parts reports Q4 sales for Automotive Group up 11.4% »

Fourth quarter sales for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

CHFS

CHF Solutions

$10.05

0.75 (8.06%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Hot Stocks
CHF Solutions enters South American market with Bragenix distribution agreement »

CHF Solutions announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MRVL

Marvell

$18.82

-0.37 (-1.93%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Upgrade
Marvell rating change  »

Marvell upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

GPL

Great Panther Silver

$0.80

0.0576 (7.76%)

08:36
02/19/19
02/19
08:36
02/19/19
08:36
Hot Stocks
Great Panther Silver announces court approval for acquisition of Beadell »

Great Panther Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

NUVA

NuVasive

$58.65

0.12 (0.21%)

08:36
02/19/19
02/19
08:36
02/19/19
08:36
Hot Stocks
NuVasive receives FDA 510(k) clearance for Precice Bone Transport System »

NuVasive announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.